We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
MOG peptide (35-55)
Myelin Oligodendrocyte Glycoprotein Peptide Fragment 35-55
Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys
Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys
As low as
$247.75
In stock
Ref
00110288
The MOG peptide (35-55) has been described to induce autoimmune encephalomyelitis associated with Parkinson disease. It induces extensive plaque-like demyelination after a single injection. Immunization with this peptide blocks the regeneration of dopaminergic neurons injured with MPTP.
ID Covalab | pep90001 |
---|---|
Product type | Peptides |
Target domain | 33 - 55 |
Activity cross reaction | Mouse Gene ID: 17441 Uniprot ID: Q61885 Rat Gene ID: 24558 Uniprot ID: Q63345 |
Species | Ms, Rat |
Labelling | None |
Antibody / Antigen | pab72397 |
Sequence | MEVGWYRSPFSRVVHLYRNGK |
Modifications | None |
Pureté | >98% |
Preservative | None |
Storage instructions | Store at −20°C |
Target | MOG (35-55) |
CAS Number | 163913-87-9 |
Publication | * Marrocco R et al. Positive regulation of Vav1 by Themis controls CD4 T cell pathogenicity in a mouse model of central nervous system inflammation. Cell. Mol. Life Sci. 81, 161 (2024). *Yshii et al.Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation NATURE IMMUNOLOGY. 2022 Juin. |
Write Your Own Review